Patents Assigned to Advanced Peptides & Biotechnology Sciences
  • Patent number: 5567682
    Abstract: The present invention relates to a method of treating the symptoms of Alzheimer's disease by the intranasal administration of a therapeutically effective amount of specific short chain peptides, in particular peptide T, to patients. Intranasal administration of the defined short chain peptides promotes neuronal survival for reducing or halting the progressive neuronal degeneration which occurs in Alzheimer's disease.
    Type: Grant
    Filed: November 29, 1994
    Date of Patent: October 22, 1996
    Assignee: Advanced Peptides and Biotechnology Sciences
    Inventor: Candace B. Pert
  • Patent number: 5534495
    Abstract: The present invention relates to methods of treating diabetic and other non-HIV related neuropathic pain. The methods involve administration of an effective amount of defined linear peptides to patients. The peptides can be administered for example, as a powder or a solution obtained by dissolving a powder in a pharmaceutically acceptable solvent. Intranasal or sublingual administration of the defined peptides is the most preferred treatment.
    Type: Grant
    Filed: February 8, 1995
    Date of Patent: July 9, 1996
    Assignee: Advanced Peptides and Biotechnology Sciences
    Inventors: Candace B. Pert, Michael R. Ruff
  • Patent number: 5446026
    Abstract: The present invention is directed to Cholic, Chenodeoxycholic and deoxycholic acid derivatives of a peptide having the sequence: Pro-Arg-Thr-Asn-Thr-Gly-Ser-Gly-Thr-Pro-amide and use thereof in inducing analgesia.
    Type: Grant
    Filed: February 19, 1993
    Date of Patent: August 29, 1995
    Assignee: Advanced Peptides & Biotechnology Sciences
    Inventors: Michael R. Ruff, Joanna M. Hill, Lawrence D. Kwart, Candace B. Pert